Highlights
NASDAQ: MDGL       Madrigal Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
110.24   +1.92 (1.77%)  106.23 - 113.12  242,000

Overview

 
Avg Volume (4 weeks):345,522
4 Weeks Range:106.23 - 149.66
4 Weeks Price Volatility (%):
9.23%
52 Weeks Range:77.00 - 325.98
52 Weeks Price Volatility (%):
13.35%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. In addition, MGL-3196 also reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. Geographically, all the business activity is functioned through the US.

  Be the first to like this.
 


 

2779  5187  625  152 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GE 7.10-0.10 
 SPY 260.47-4.90 
 EEM 39.83-0.57 
 BAC 24.48+0.08 
 AMD 19.90+0.04 
 XLF 24.24-0.24 
 JNJ 133.00-14.84 
 QQQ 161.08-4.02 
 EFA 60.46-0.79 
 GDX 20.12-0.36 
Partners & Brokers